KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Other Non-Current Liabilities (2016 - 2026)

Bio-Rad Laboratories has reported Other Non-Current Liabilities over the past 18 years, most recently at $198.4 million for Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 14.62% to $198.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $198.4 million through Mar 2026, up 14.62% year-over-year, with the annual reading at $199.1 million for FY2025, 12.36% up from the prior year.
  • Other Non-Current Liabilities was $198.4 million for Q1 2026 at Bio-Rad Laboratories, roughly flat from $199.1 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $209.6 million in Q2 2025 and troughed at $173.1 million in Q1 2025.
  • The 5-year median for Other Non-Current Liabilities is $195.9 million (2022), against an average of $193.5 million.
  • Year-over-year, Other Non-Current Liabilities dropped 21.31% in 2022 and then increased 14.62% in 2026.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $195.9 million in 2022, then fell by 0.47% to $195.0 million in 2023, then dropped by 9.13% to $177.2 million in 2024, then rose by 12.36% to $199.1 million in 2025, then decreased by 0.35% to $198.4 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Other Non-Current Liabilities are $198.4 million (Q1 2026), $199.1 million (Q4 2025), and $207.5 million (Q3 2025).